跳至主要内容
临床试验/ISRCTN55359097
ISRCTN55359097已完成未知

A method comparison study comparing intra- and inter-user reproducibility of FeNO measurement using the NObreath® V2

Bedfont® Scientific Ltd0 个研究点目标入组 186 人开始时间: 2020年9月4日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
186

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged 7 years or above
  • 2. If on allergy immunotherapy treatment this must be a stable regimen during the study
  • 3. Be capable of producing valid FeNO measurements via the NObreath®
  • 4. Be capable of performing spirometry in accordance with ATS/ERS criteria

排除标准

  • 1. Hospitalisation related to asthma in the past 6 months
  • 2. Use of oral corticosteroid in the 4 weeks prior to visit 1
  • 3. Use of biological therapies e.g. mepolizumab in 12 weeks prior to visit 1
  • 4. Other respiratory diseases e.g. COPD or cystic fibrosis
  • 5. Known intolerance to inhaled corticosteroids or salbutamol
  • 6. Cardiovascular conditions:
  • 6.1. Coronary artery disease
  • 6.2. High blood pressure
  • 6.3. Heart failure
  • 6.4. Diagnosed abnormality of heart rhythm
  • 7. A smoking history of >10 packs per year
  • 8. Pregnant

研究者

发起方
Bedfont® Scientific Ltd

相似试验